A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.

Clinical trial NCT06383403 · COMPLETED

Trial details

NCT number: NCT06383403
Sponsor: Ipsen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Biliary Cholangitis

Start date: 2024-07-09
Primary completion: 2026-06-16
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.